Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
05/2008
05/21/2008CN101182464A Extracellular matrix coated surface for culturing cells
05/21/2008CN101182356A Clenbuterol complete antigen and method for preparing monoclonal antibody thereof
05/21/2008CN101182354A Vegetable drought-resistance related protein as well as coding gene and application thereof
05/21/2008CN101180952A Tissue culture rapid breeding method of Chinese medicine abrotanum
05/21/2008CN101180951A Tissue cultivation quick breeding method of orchid
05/21/2008CN101180949A Stem tip tissue rapid cultivating and seedling method of algam dendrobium nobile
05/21/2008CN101180948A Method for establishing high-efficiency somatic cell embryogenesis regeneration plant of plantain banana and Brazilian banana
05/21/2008CN100389196C Cancer cell vaccine
05/21/2008CN100389194C Insulin secretory cell extract and its application in inducing stem cell differentiation
05/21/2008CN100389193C Method for safe continuous enclosed cell culture, virus production/ inactivation
05/21/2008CN100389192C Substances for preventing and treating autoimmune diseases
05/20/2008US7375266 Plants and seeds of corn variety LH372
05/20/2008US7375265 Plants and seeds of corn variety LH326
05/20/2008US7375264 Inbred corn line PHACV
05/20/2008US7375261 Soybean cultivar S06-WW169267
05/20/2008US7375258 Transgenic avians with an ovomucoid gene expression control region linked to a nucleotide sequence encoding a heterologous polypeptide
05/20/2008US7375209 comprising transcription regulating sequences with seed-preferential or seed-specific expression profiles in plants obtainable from Arabidopsis thaliana genes
05/20/2008US7375208 nucleic acid sequences comprising monocotyledonous regulatory sequences that are located upstream of the 5' end of structural coding sequences and transcribed in monocotyledonous tissue, more specifically in wheat tissue preferably lemma, palea or glume
05/20/2008US7375205 Elongase genes and uses thereof
05/20/2008US7375201 derived from Halcurias sp. L sea anemone and not Aequorea victoria and having a novel primary structure; recombinant vector; excitation maximum wavelength is 494 nm, and the fluorescence maximum wavelength is 506 nm; marker protein; reporter protein to determine promoter activity
05/20/2008US7375199 Cancer-associated genes
05/20/2008US7375196 PRO19814 antibodies
05/20/2008US7375195 Vectors with DNA encoding pro polypeptides
05/20/2008US7375187 Alzheimer's disease secretase, APP substrates therefor, and uses therefor
05/20/2008US7375179 PRO19680 polypeptides
05/20/2008US7375117 Polypeptides
05/20/2008US7375093 Nuclear receptor-based inducible gene expression system
05/20/2008US7375092 Blocking mitosis; transfection nucleic acid; anticancer agents
05/20/2008US7375079 Recombinant expression system for production of a peptide capable of inhibiting the protease activity of Botulinum toxin B or tetanus toxin which expression system comprises a nucleotide sequence encoding the peptide operably linked to a control sequence for effecting expression
05/20/2008US7374938 Preparing fiber containing beta 1,4 glucan chains for use in food procesing, films, microcapsules and medical fibers
05/20/2008US7374937 in vitro methods of inducing proliferation of stromal cells without inducing differentiation of mesenchymal stem cells; use in gene therapy and transplantation; initial density of isolated cells is less than 50 cells per sq cm of growth surface, incubating; contacting cells with antibody to Lipocortin II
05/20/2008US7374936 Generation of therapeutic radioconjugate; load isotope onto binding support, elute long lived isotopes, join isotope to targeting particle, recover radioconjugate
05/20/2008US7374935 Human Rgr oncogene and truncated transcripts thereof detected in T cell malignancies, antibodies to the encoded polypeptides and methods of use
05/20/2008US7374934 Immortalization stem cell; animal growth regulators; formingantibodies
05/20/2008US7374933 Diagnosis, drug screening, clinical trial monitoring, the treatment of physiological disorders or diseases, and cosmetic or nutriceutical applications
05/20/2008US7374925 Penicillium funiculosum mutant strain
05/20/2008US7374921 Cellulase tolerant to surfactants
05/20/2008US7374918 Enhanced sarcosine oxidase for use in measurement of creatinine concentration in human serum or urine; diagnosing renal disorders
05/20/2008US7374912 Nucleic acids encoding chimeric interleukin-6 soluble receptor/ligand protein, analogs thereof and uses thereof
05/20/2008US7374911 Cytokine polypeptide for use in diagnosis, prevention and treatment of immunological and/or inflammatory disorders
05/20/2008US7374909 mediated by receptors of the TNF/NGF superfamily of receptors; originally designated CBK, but now designated B1; DNA sequence: vector
05/20/2008US7374908 Microorganism and production of carotinoid compounds thereby
05/20/2008US7374903 Surface layer providing the substrate with topographical features with nanoscale dimension, having the capacity to adapt, facilitate, influence, control or inhibit at least one cell or tissue behavior or response thereon and/or therebetween
05/20/2008US7374889 Human sphingosine-1-phosphate phosphatase and inhibition methods
05/20/2008US7374870 Systems and methods for removing viral agents from blood
05/20/2008US7374774 Electroprocessed material made by simultaneously electroprocessing a natural protein polymer and two synthetic polymers
05/20/2008US7374763 Foot-and-Mouth Disease virus (FMDV), or their epitopes; vaccine from the grafting of peptide epitopes derived from FMDV into swine antibody CDR loops, FMDV peptide epitopes are cloned by polymerace chain reaction PCR from VP1 gene of FMDV
05/20/2008US7374760 Methods and compositions for nerve regeneration
05/20/2008US7374752 Reovirus for the treatment of cellular proliferative disorders
05/20/2008CA2473759C Antibodies for detecting ecstasy-class analytes
05/20/2008CA2456070C Intrauterine device, method of making such a device and method for putting active elements within the uterine cavity
05/20/2008CA2283231C Adenovirus vectors containing heterologous transcription regulatory elements and methods of using same
05/20/2008CA2128862C Homogenotization of gene-targeting events
05/15/2008WO2008058273A2 Dedifferentiation of adult mammalian cardiomyocytes into cardiac stem cells
05/15/2008WO2008058233A2 In vivo bioreactors and methods of making and using same
05/15/2008WO2008058216A2 Enriched stem cell and progenitor cell populations, and methods of producing and using such populations
05/15/2008WO2008057481A1 Ventricular assist device capable of implantation of stem cells
05/15/2008WO2008057162A2 Native (telopeptide) placental collagen compositions
05/15/2008WO2008056963A1 Method for proliferating stem cells with leptin
05/15/2008WO2008056833A1 ANTI-HUMAN Dlk-1 ANTIBODY SHOWING ANTI-TUMOR ACTIVITY IN VIVO
05/15/2008WO2008056779A1 Method for culture and passage of primate embryonic stem cell, and method for induction of differentiation of the embryonic stem cell
05/15/2008WO2008056734A1 Method for producing dendritic cells from human embryonic stem cells
05/15/2008WO2008056705A1 M cell-specific antibody
05/15/2008WO2008056179A1 Novel compositions and uses thereof
05/15/2008WO2008056173A2 Pluripotent cells from the mammalian late epiblast layer
05/15/2008WO2008056166A2 Differentiation of pluripotent cells into primary germ layer progenitors
05/15/2008WO2008055671A2 Method for the purification of at least one target substance that is to be identified
05/15/2008WO2008055361A1 E3 UBIQUITM LIGASE MKRNL AS A MARKER FOR MAMMALIAN STEM CELL PLUπPOTENCY AND METHODS AND USES THEREOF
05/15/2008WO2008055354A1 Rna-loaded dendritic cell compositions for eliciting cd4+ t cell help and related methods
05/15/2008WO2008034929B1 Method for culturing and maintaining mammal multipotential trunk cells and progenitor cells in a non-differentiated state
05/15/2008WO2008028192A3 Variable region sequences of il-31 monoclonal antibodies and methods of use
05/15/2008WO2008008844A8 Mpo1 gene and protein and methods of use
05/15/2008WO2007150053B1 Composition and method for delivery of bmp-2 amplifier/co-activator for enhancement of osteogenesis
05/15/2008WO2007146106A3 Procurement, isolation and cryopreservation of maternal placental cells
05/15/2008WO2007136893A3 Anti-fgf19 antibodies and methods using same
05/15/2008WO2007135563A3 Use of glis3 for preparing functional pancreatic beta-cells
05/15/2008WO2007050866A8 Oligodendrocyte-myelin glycoprotein compositions and methods of use thereof
05/15/2008US20080115243 Transgenic Plants Expressing Intein Modified Proteins and Associated Processes for Bio-Pharmaceutical Production
05/15/2008US20080115241 Expression vector comprising nucleotide sequences coding latobacillus hydrolase for use in enhancing digestibility of animal feeds
05/15/2008US20080115237 Novel ecdysone receptor-based inducible gene expression system
05/15/2008US20080114079 TRPM2-specfic inhibitors
05/15/2008US20080114078 Rgd-enriched gelatine-like proteins with enhanced cell binding
05/15/2008US20080114070 Compositions and methods for restoring sensitivity of tumor cells to antitumor therapy and inducing apoptosis
05/15/2008US20080114015 NF-kB inhibitors and uses thereof
05/15/2008US20080114010 Novel Substituted Imidazole Compounds
05/15/2008US20080113933 polynucleotide molecules that encode the Chlamydia polypeptides designated 60 kDa cysteine-rich membrane proteine which can be used to prevent, treat, and diagnose Chlamydia infection
05/15/2008US20080113930 an RNA strand (the antisense strand) having a region which is less than 30 nucleotides in length, complementary to at least a part of the PCSK9 gene; antihyperlipemia agent
05/15/2008US20080113910 Polypeptides or peptides with no risk for viral infection, pathogens, prions; not evoke immune response; gelatine consists of native human collagen sequences; coating on scaffolds for tissue engineering, implant, transplant materials; component of drug delivery systems for inhibition of cancer metastasis
05/15/2008US20080113906 Sushi Peptide Multimer
05/15/2008US20080113898 Methods for detecting and inhibiting angiogenesis using peptides
05/15/2008US20080113435 Transforming bone marrow stromal cells with vector comprising notch receptor, exposing cells to jagged 1 protein, culture and recover myoblast
05/15/2008US20080113434 Propagating non-hematopoietic stem cells by non-static, non-adherent suspension in serum-deprived nutrient medium; regenerative medicine; tissue engineering
05/15/2008US20080113433 Compositions and methods useful for culturing differentiable cells
05/15/2008US20080113432 Methods and compositions for reanimating cryopreserved oocytes
05/15/2008US20080113431 Methods and compositions for cryopreserving oocytes
05/15/2008US20080113430 Nucleic acid and amino acid sequences relating to streptococcus pneumoniae for diagnostics and therapeutics
05/15/2008US20080113429 Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
05/15/2008US20080113428 Novel Polypeptide Hormone Phosphatonin
05/15/2008US20080113400 Methods and Devices for Culturing Stem Cells
05/15/2008US20080113387 Immunoassay for Prion Disease